Scancell Holdings doses first patient with iSCIB1+
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), a developer of immunotherapies for cancer and infectious diseases, has reached a pivotal milestone in its...
Source: proactiveinvestors.co.uk
Stay updated with breaking news from Ls Prasad Kellati. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), a developer of immunotherapies for cancer and infectious diseases, has reached a pivotal milestone in its...